Gary Clark: Unfiltered

Insightful analysis on the financial currents, corporate maneuvers, and innovations defining our era.

GC
Editor
Gary Clark

About This Column

Gary Clark is a commentator and strategist exploring the intersection of finance and industrial transformation. Transitioning from his deep dive into corporate maneuvers, Gary now delivers daily dispatches on the broad forces defining the 2026 economic landscape - from the evolution of global supply chain finance to the impact of AI on asset allocation. With a reputation for providing "the story behind the numbers," he offers a unique lens on what drives market performance in a complex world. His writing is essential for anyone seeking to understand the "why" of today’s market to predict the "what" of tomorrow.

Displaying items 481-500 of 573 in total

From Cannabis to Code: Mixie's Audacious Bet on the Digital Twin Future

Read full article
BriefGlance

Planet Green Bets on a 400-Year-Old Tea Legacy to Revive Fortunes

Read full article
BriefGlance

GSL's 'Three-for-One' Shipping Deal: A Masterclass in Value

Read full article
GSL's 'Three-for-One' Shipping Deal: A Masterclass in Value

U.S. Gold Corp. Seeks London Capital for American Metals

Read full article
U.S. Gold Corp. Seeks London Capital for American Metals

MAX Power's Hydrogen Pivot: New CEO Signals Commercialization Push

Read full article
MAX Power's Hydrogen Pivot: New CEO Signals Commercialization Push

Coveo's AWS Play: Solving GenAI's Billion-Dollar Trust Problem

Read full article
Coveo's AWS Play: Solving GenAI's Billion-Dollar Trust Problem

Bristol Myers' Dual-Platform Gambit Redefines Hematology Investing

Read full article
Bristol Myers' Dual-Platform Gambit Redefines Hematology Investing

The pTau Predictor: How ProMIS Aims to De-Risk Alzheimer's Drug Trials

Read full article
The pTau Predictor: How ProMIS Aims to De-Risk Alzheimer's Drug Trials

Medicus Unifies Command for a High-Stakes, Three-Front Biotech Push

Read full article
Medicus Unifies Command for a High-Stakes, Three-Front Biotech Push

Endeavour Silver’s $300M Gambit: Debt Relief for a Silver Giant

Read full article
Endeavour Silver’s $300M Gambit: Debt Relief for a Silver Giant

TriplePoint's Capital Coup: A Strategic Bet on Venture's Future

Read full article
TriplePoint's Capital Coup: A Strategic Bet on Venture's Future

Merck's Two-Pronged Attack on Alzheimer's: A Calculated Pivot

Read full article
Merck's Two-Pronged Attack on Alzheimer's: A Calculated Pivot

Mirasol's High-Tech Gamble in Chile's Copper-Gold Hotspot

Read full article
Mirasol's High-Tech Gamble in Chile's Copper-Gold Hotspot

Mobix Labs Signals Turnaround, But Path to Profit Remains Steep

Read full article
Mobix Labs Signals Turnaround, But Path to Profit Remains Steep

NY Graphite Project Gets Federal Backing to Break China's Mineral Grip

Read full article
NY Graphite Project Gets Federal Backing to Break China's Mineral Grip

Viasat's High-Seas Gambit: A Hybrid Bet in the LEO Satellite Race

Read full article
Viasat's High-Seas Gambit: A Hybrid Bet in the LEO Satellite Race

Saba's Payout Puzzle: Income or Return of Capital?

Read full article
BriefGlance

Rubico's Reverse Split: A Lifeline or an Anchor for the Shipper?

Read full article
Rubico's Reverse Split: A Lifeline or an Anchor for the Shipper?

BNC Taps Regulatory Heavyweight for Its High-Stakes BNB Treasury Bet

Read full article
BNC Taps Regulatory Heavyweight for Its High-Stakes BNB Treasury Bet

Faraday Future Bets Big on Dubai, But Can It Deliver on its Promises?

Read full article
Faraday Future Bets Big on Dubai, But Can It Deliver on its Promises?
UCID: 7